APOE and Alzheimer disease: While individuals carrying apoE ε4 homozygotes have a 12-fold increased risk for AD, those carrying apoE ε4 heterozygotes have a 2- to 3-fold increased risk for AD and the apoE4 reduces the age of AD onset [3].